Home LiteratureArticle Details
PMID: 2185036 Published · ppublish English Journal Article Review

'Quantal' Ca2+ release and the control of Ca2+ entry by inositol phosphates--a possible mechanism.

FEBS letters ·Vol. 263 ·No. 1 ·1990-04-09 ·Pages 5-9

Irvine RF

Abstract

The release of Ca2+ from intracellular stores by sub-optimal doses of inositol trisphosphate has been shown to be dose-related ('quantal'), and a simple model is proposed here to account for this phenomenon. It is suggested that there is a regulatory Ca2(+)-binding site on, or associated with, the luminal domain of the InsP3 receptor, which allosterically controls Ca2+ efflux, and the affinity for Ca2+ of that site is modulated by InsP3 binding to the cytoplasmic domain of the receptor; a similar mechanism applied to the ryanodine receptor might also explain some aspects of Ca2(+)-induced Ca2+ release. The stimulated entry of Ca2+ into a cell which occurs upon activation of inositide-linked receptors has been variously and confusingly proposed to be regulated by InsP3, InsP4, and/or a 'capacitative' Ca2+ pool; the mechanism of InsP3 receptor action suggested here is shown to lead to a potential reconciliation of all these conflicting proposals.

MeSH Terms
Animals Calcium/metabolism Cell Membrane/metabolism Endoplasmic Reticulum/metabolism Inositol Phosphates/metabolism Models, Biological Signal Transduction
Chemicals
Inositol Phosphates Calcium
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Irvine R F
Biochemistry Department, AFRC Institute of Animal Physiology and Genetics Research, Babraham, Cambridge, UK.
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1990-04-09
Pages
5-9
Language
English
Region
England
NLM ID
0155157
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com